Just reported
From Humana's results release of 6. November 2026; its quarterly report has since been filed.
Actual
41,16B $
+26 % y/y
+0,7 % q/q
Guided
—
No guide given
Actual
1,33 $
-18 % y/y
-77 % q/q
Guided
—
No guide given
Actual
75M $
-81 % y/y
-94 % q/q
Guided
—
No guide given
Full year 2026
Set against the company's own guidance and the same quarter a year earlier, not analysts' estimates, which we do not hold. Adjusted figures are the company's own non-GAAP measures, as stated in the release.
Die Umsatzanteile sind Schätzungen für quarter ended March 31, 2026 und keine Zahlen aus einem eingereichten Bericht.
Medicare Advantage plans
Health plans for people eligible for Medicare that cover hospital and medical care, often with prescription drugs, care coordination and extra benefits.
Medicare Part D prescription drug plans
Prescription coverage sold either as a stand-alone plan or as part of many Medicare Advantage plans.
Medicaid managed-care plans
Health coverage for people eligible for Medicaid, provided under contracts with state governments.
Medicare Supplement and employer specialty insurance
Medicare Supplement plans help pay costs not covered by traditional Medicare; employer specialty policies cover benefits such as dental, vision, life and disability.
CenterWell Pharmacy
A mail-order and specialty pharmacy that fills prescriptions and supplies medicines and health products.
CenterWell primary and home care
Primary-care clinics focused mainly on older adults, home health visits, and coordination of services such as home infusion and medical equipment.
Humana’s largest business sells health insurance plans, especially Medicare Advantage plans, which cover hospital and medical care and often include prescription drugs. The federal Centers for Medicare & Medicaid Services pays Humana for much of this coverage; Humana also contracts with states for Medicaid plans and sells insurance to employers and individuals. Its CenterWell businesses provide pharmacy services, primary care and care in patients’ homes.
Gebaut aus den eigenen Einreichungen von Humana Inc. bei der US-Börsenaufsicht Securities and Exchange Commission (SEC). Die Zahlen sind wie berichtet, die Historie je Aktie auf die heutige Aktienbasis umgerechnet. Dies beschreibt ein Unternehmen — es ist keine Anlageberatung und keine Kauf- oder Verkaufsempfehlung.
The themes Humana is part of, the highest-graded companies in its industry, and the companies in its sector whose grade rose recently.
Graded A or B and worth $2B or more: A first, then the largest.
Rose to A or B on a filing in the last 90 days, worth $2B or more: largest first.
443,94 $-0,6 %Schluss 12. Nov.
Zahlen bis 30. September 2026, aus dem 10-Q vom 6. November 2026
Humana sells Medicare Advantage health insurance to older adults and people with disabilities, alongside prescription coverage and care services.
Grade B
Das Band unter dem Kurs zeigt die Note an jedem Tag – gebildet nur aus den Unterlagen, die bis dahin veröffentlicht waren.
Zeigt 2 von 40 Quartalen der Notenhistorie von Humana Inc.. Die übrigen 38 reichen zurück bis November 2016.